Oppenheimer Asset Management Inc. Sells 51,113 Shares of Merck & Co., Inc. $MRK

Oppenheimer Asset Management Inc. reduced its stake in Merck & Co., Inc. by 9.2% in the fourth quarter, selling 51,113 shares and now owning 502,885 shares worth $52.93 million. This comes as Merck’s stock has seen a 1.5% decrease, yet the company reported strong Q1 earnings, beating consensus estimates with $16.29 billion in revenue. Analysts have a “Moderate Buy” rating on MRK, with an average target price of $128.47, despite some institutional selling and insider transactions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin